GOLM1 and hepatocellular carcinoma: The results showed that CLD patients with cirrhosis had the highest serum GP73 level (127.90 ng/mL, 82.56 ng/mL–192.40 ng/mL) compared to patients with HCC (100.50 ng/mL, 60.62 ng/mL–161.50 ng/mL, p < 0.001) and non-cirrhotic CLD (46.42 ng/mL, 30.60 ng/mL–66.90 ng/mL, p < 0.001).